CardiaTec Biosciences

About:

CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

Website: https://www.cardiatec.ai/

Top Investors: Montage Ventures, O2h Ventures, University of Cambridge Enterprise, APEX Ventures, Continuum Health Ventures

Description:

CardiaTec is a TechBio business that uses computational tools to unravel the biology underlying cardiovascular illness. CardiaTec uses massive and high-dimensional human omics data to better understand complicated disease biology and identify novel and differentiated therapies.

Total Funding Amount:

$8.17M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2021-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-09-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai